GlaxoSmithKline Consumer Healthcare gets CCI’s nod for merger deal with HUL

28 Jan 2019 Evaluate

GlaxoSmithKline Consumer Healthcare has received an approval from the Competition Commission of India (CCI) for its merger deal with Hindustan Unilever (HUL).

The scheme remains subject to the receipt of other necessary statutory and regulatory approvals under applicable laws, including by the NSE, SSE, SEBI, NCLT and the respective shareholders and creditors of HUL and the company.

Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 1246.65
Varun Beverages 479.95
Britannia Inds 5961.10
LT Foods 397.00
Hatsun Agro Product 1034.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×